Flavahanet al. 29 showed that gain-of-function mutations in theIDH gene cause hyper-methylation of CpG sites as well as the GC-rich CTCF binding motif; this reduces CTCF binding at a subset of CTCF sites in mutant glioma cells. The gene discussed is CTCF; the disease is central nervous system cancer.